UNCY 8-K 2026-09-28

Unicycive Therapeutics, Inc. (UNCY) 8-K dated 2026-09-28 — accession 0001213900-26-104076. This URL is the filing, not the UNCY hub.

Unicycive Therapeutics, Inc. (UNCY) is a biotechnology company listed on NASDAQ.

Unicycive Therapeutics, Inc. filed a 8-K on 2026-09-28. Accession 0001213900-26-104076.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported UNCY revenue for 2023-12-31 was $675.0K. Net income was -$30.5M. UNCY currently screens at market cap $195.0M.

Not investment advice. The UNCY SEC hub lists recent forms. The stock page is the research view.